An international task force of academic and industry leaders in sarcopenia research met on December 5, 2012 in Orlando, Florida to develop guidelines for designing and executing randomized clinical trials of sarcopenia treatments. The Task Force reviewed results from previous trials in related disease areas to extract lessons relevant to future sarcopenia trials, including practical issues regarding the design and conduct of trials in elderly populations, the definition of appropriate target populations, and the selection of screening tools, outcome measures, and biomarkers. They discussed regulatory issues, the challenges posed by trials of different types of interventions, and the need for standardization and harmonization. The Task Force concluded with recommendations for advancing the field toward better clinical trials.
Designing pharmaceutical trials for sarcopenia in frail older adults : EU/US task force recommendations / B. Vellas, M. Pahor, T. Manini, D. Rooks, J.M. Guralnik, J. Morley, S. Studenski, W. Evans, C. Asbrand, R. Fariello, S. Pereira, Y. Rolland, G. Abellan Van Kan, M. Cesari, W.M.C. Chumlea, R. Fielding. - In: THE JOURNAL OF NUTRITION, HEALTH & AGING. - ISSN 1279-7707. - 17:7(2013), pp. 612-618.
Designing pharmaceutical trials for sarcopenia in frail older adults : EU/US task force recommendations
M. Cesari;
2013
Abstract
An international task force of academic and industry leaders in sarcopenia research met on December 5, 2012 in Orlando, Florida to develop guidelines for designing and executing randomized clinical trials of sarcopenia treatments. The Task Force reviewed results from previous trials in related disease areas to extract lessons relevant to future sarcopenia trials, including practical issues regarding the design and conduct of trials in elderly populations, the definition of appropriate target populations, and the selection of screening tools, outcome measures, and biomarkers. They discussed regulatory issues, the challenges posed by trials of different types of interventions, and the need for standardization and harmonization. The Task Force concluded with recommendations for advancing the field toward better clinical trials.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Designing Pharmaceutical Trials for Sarcopenia in Frail Older Adults- EU:US Task Force Recommendations. - Vellas et al. (2013).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
160.28 kB
Formato
Adobe PDF
|
160.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
